Shaymaa Bahnassy

7PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 01, 2026
Impact of Trastuzumab and Pertuzumab on HER2 Localization and the Estrogen Receptor Cistrome in ER+/HER2+ Breast Cancer.

|Mar 13, 2025
Generalized Evolutionary Classifier for Evolutionary Guided Precision Medicine.

Matthew McCoy, Chen-Hsiang Yeang, Shaymaa Bahnassy

|Oct 28, 2024
Glutamate Transport Proteins and Metabolic Enzymes are Poor Prognostic Factors in Invasive Lobular Carcinoma.

Todd A Young, Shaymaa Bahnassy, Theresa C Abalum

|Dec 19, 2023
WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic Cancers.

Joseph L Sottnik, Madeleine T Shackleford, Sydney K Robinson

|Oct 28, 2023
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer.

Shaymaa Bahnassy, Hillary Stires, Lu Jin

|Sep 28, 2023
Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer.

Ayodeji O Olukoya, Hillary Stires, Shaymaa Bahnassy

Pageof 2

Frequent Collaborators

7 joint publications

Rebecca B Riggins

4 joint publications

Stanley Tam

3 joint publications

Matthew J Sikora

3 joint publications

Suman Ranjit